Arizona State University home to new 9.4T cryogen-free MRI system

Arizona State University is now home to a highly-advanced 9.4-Tesla cryogen-free high-field imaging system that's being used to support its medical imaging research efforts. 

The scanner was recently installed at the Tempe, Arizona, campus by MR Solutions and is being managed by the ASU BioSciences Core. The superconducting system will provide soft-tissue contrast in tissue microenvironments and bolster the university's continued pursuit of early disease detection.

The scanner has various field capabilities including 9.4T, 7T and 3T, and is said to be compatible with simultaneous PET/MRI as well.

In addition to its multi-field potential, the scanner also utilizes a cryogen-free, dry magnet technology. This innovative technology removes the need for liquid helium and liquid nitrogen that most MRI systems require to cool down. In turn, the machine is much smaller and lighter than a traditional scanner, so it can be installed in more compact spaces. 

“The MR Solutions multi-field Powerscan MRI system will fill a critical need for a state-of-the-art preclinical MRI facility at ASU and accelerate cutting-edge basic and translational research in neuroscience, cancer, tissue engineering, metabolism, and drug discovery for scientists at ASU and the region,” Vikram Kodibagkar, associate professor with ASU’s School of Biological and Health System Engineering, said in a statement.

MR Solutions has completed more than 2,000 installations across the world and has received the Queen’s Award twice for their innovations.

Hannah murhphy headshot

In addition to her background in journalism, Hannah also has patient-facing experience in clinical settings, having spent more than 12 years working as a registered rad tech. She began covering the medical imaging industry for Innovate Healthcare in 2021.

Around the web

A total of 16 cardiology practices from 12 states settled with the DOJ to resolve allegations they overbilled Medicare for imaging agents used to diagnose cardiovascular disease. 

CCTA is being utilized more and more for the diagnosis and management of suspected coronary artery disease. An international group of specialists shared their perspective on this ongoing trend.

The new technology shows early potential to make a significant impact on imaging workflows and patient care.